FDA approved Vorapaxar [Zontivity] to reduce the risk of stroke and heart attacks in high-risk patients
May 15, 2014 – The U.S. Food and Drug Administration recently approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a …